financetom
Business
financetom
/
Business
/
--TJX Companies Keeps Quarterly Dividend at $0.375 a Share, Payable March 6 to Shareholders of Record Feb. 13
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--TJX Companies Keeps Quarterly Dividend at $0.375 a Share, Payable March 6 to Shareholders of Record Feb. 13
Dec 9, 2024 11:09 AM

01:56 PM EST, 12/09/2024 (MT Newswires) --

Price: 126.40, Change: +0.31, Percent Change: +0.25

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Mar 25, 2024
01:31 PM EDT, 03/25/2024 (MT Newswires) -- Consumer stocks were slipping Monday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) down 0.5% and the Consumer Discretionary Select Sector SPDR Fund (XLY) shedding 0.2%. In corporate news, Target Hospitality ( TH ) shares surged 23% after it said that its board received an unsolicited non-binding proposal from a TDR...
Exxon Mobil, JERA to Explore Development of Low-Carbon Hydrogen, Ammonia Production Project in US
Exxon Mobil, JERA to Explore Development of Low-Carbon Hydrogen, Ammonia Production Project in US
Mar 25, 2024
01:34 PM EDT, 03/25/2024 (MT Newswires) -- Exxon Mobil ( XOM ) and Japan's JERA plan to explore the development of a low-carbon hydrogen and ammonia production project in the US. JERA said Monday it will explore taking a stake in Exxon's low-carbon hydrogen production plant in Texas, which is currently under development, and procuring about 500,000 metric tons of...
National Bank Previews BCE's Q1 Results
National Bank Previews BCE's Q1 Results
Mar 25, 2024
01:18 PM EDT, 03/25/2024 (MT Newswires) -- National Bank previews BCE's Q1 results. Analyst Adam Shine is forecasting quarterly revenue of $6.028 billion, Adj. EPS $0.70 & FCF $71 million. Consensus at $6.11 billion, adjusted EPS of $0.73 & FCF at $609 million (LSEG/Bloomberg show higher figures). Maintain Outperform. Target lowered to $53, from $55. Price: 45.78, Change: -0.08, Percent...
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center
Mar 25, 2024
01:29 PM EDT, 03/25/2024 (MT Newswires) -- Biodesix ( BDSX ) said Monday it entered into a new master collaborative research agreement with Memorial Sloan Kettering Cancer Center to develop diagnostic tests for cancer treatment. Biodesix ( BDSX ) said it will utilize its genomics, proteomics, and data mining capabilities to develop and commercialize oncology biomarker assays in the collaboration,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved